carbachol has been researched along with Paranasal Sinus Diseases in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Paranasal Sinus Diseases: Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poe, RH | 1 |
| Harder, RV | 1 |
| Israel, RH | 1 |
| Kallay, MC | 1 |
1 other study available for carbachol and Paranasal Sinus Diseases
| Article | Year |
|---|---|
Chronic persistent cough. Experience in diagnosis and outcome using an anatomic diagnostic protocol.
Topics: Adult; Aged; Asthma; Bronchial Provocation Tests; Bronchitis; Carbachol; Chronic Disease; Clinical P | 1989 |